These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6157401)

  • 21. Preparation of antisera to interferon by interferon . Blue Dextran complexes.
    Inglot AD
    Methods Enzymol; 1981; 79(Pt B):585-9. PubMed ID: 6173715
    [No Abstract]   [Full Text] [Related]  

  • 22. Partial purification of human interferon by affinity chromatography.
    Anfinsen CB; Bose S; Corley L; Gurari-Rotman D
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3139-42. PubMed ID: 4370251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of human interferons to immobolized Cibacron Blue F3GA: The nature of molecular interaction.
    Jankowski WJ; von Muenchhausen W; Sulkowski E; Carter WA
    Biochemistry; 1976 Nov; 15(23):5182-7. PubMed ID: 990274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of antibodies to human interferons in mice.
    Dalton BJ; Ogburn CA; Paucker K
    Infect Immun; 1978 Feb; 19(2):570-4. PubMed ID: 631890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human fibroblast interferon. An improved purification.
    Knight E; Fahey D
    J Biol Chem; 1981 Apr; 256(8):3609-11. PubMed ID: 6163770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper chelate affinity chromatography of human fibroblast and leucocyte interferons.
    Chadha KC; Grob PM; Mikulski AJ; Davis LR; Sulkowski E
    J Gen Virol; 1979 Jun; 43(3):701-6. PubMed ID: 479851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of mouse natural killer cell activity by type II interferon.
    Senik A; Stefanos S; Kolb JP; Lucero M; Falcoff E
    Ann Immunol (Paris); 1980; 131C(3):349-61. PubMed ID: 6157349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of murine and human interferons. A review of the literature of the 1970s.
    Berg K
    Acta Pathol Microbiol Immunol Scand Suppl; 1982; 279():1-136. PubMed ID: 6182743
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple active sites on human interferons.
    Paucker K; Dalton BJ; Ogburn CA; Törmä E
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4587-91. PubMed ID: 53841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic properties and heterospecific antiviral activities of human leukocyte interferon species.
    Paucker K; Dalton BJ; Torma ET
    Adv Exp Med Biol; 1978; 110():75-84. PubMed ID: 83098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of human fibroblast interferon prepared from modified fibroblasts.
    Tan YH
    Methods Enzymol; 1981; 78(Pt A):422-30. PubMed ID: 6173624
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on Brucella interferon: chromatographic behaviour and purification.
    Bousquet-Ucla C; Wietzerbin J; Falcoff E
    Arch Virol; 1980; 63(1):57-68. PubMed ID: 6154449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose.
    Ogburn CA; Berg K; Paucker K
    J Immunol; 1973 Oct; 111(4):1206-18. PubMed ID: 4728682
    [No Abstract]   [Full Text] [Related]  

  • 34. [An immunosorbent for interferon purification].
    Garipova MI; Monakov IuB; Baschenko IA; Frolova IS; Kleeva OB; Kuznetsov VP
    Vopr Virusol; 1993; 38(3):129-32. PubMed ID: 7521101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some biological activites of rabbit anti-interferon serum.
    Fuchsberger N; Borecký L; Hajnická V; Styk B
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):715-8. PubMed ID: 597018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The chromophore of blue dextran: a powerful ligand for the purification of interferon by affinity chromatography].
    de Maeyer-Guignard J; de Maeyer E
    C R Acad Hebd Seances Acad Sci D; 1976 Sep; 283(6):709-11. PubMed ID: 825322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally occurring anti-interferon antibodies in Lou/c rats.
    De Maeyer-Guignard J; Cachard-Thomas A; De Maeyer E
    J Immunol; 1984 Aug; 133(2):775-8. PubMed ID: 6203979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of anti-IFN-beta sera with chemically synthetic IFN-beta peptide fragment (1 - 13).
    Shimizu F; Ohmoto Y; Imagawa K
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1149-56. PubMed ID: 6174125
    [No Abstract]   [Full Text] [Related]  

  • 39. NH2-terminal amino acid sequence of human fibroblast interferon.
    Stein S; Kenny C; Friesen HJ; Shively J; Del Valle U; Pestka S
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5716-9. PubMed ID: 6160579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The purification and characterization of interferons.
    Zoon KC; Smith ME
    Horiz Biochem Biophys; 1982; 6():123-35. PubMed ID: 6194096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.